Jubilant Pharmova is trading -1.16% lower at Rs 1,156.90 as compared to its last closing price. Jubilant Pharmova has been trading in the price range of 1,183.10 & 1,150.05. Jubilant Pharmova has given 6.03% in this year & -2.47% in the last 5 days. Jubilant Pharmova has TTM P/E ratio 16.91 as compared to the sector P/E of 22.90.There are 3 analysts who have initiated coverage on Jubilant Pharmova. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 153.60 Crores in its last quarter.Listed peers of Jubilant Pharmova include Eris Lifesciences (-0.54%), Alembic Pharmaceuticals (-0.21%), Jubilant Pharmova (-1.16%).The Mutual Fund holding in Jubilant Pharmova was at 3.66% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Jubilant Pharmova was at 17.23% in 31 Mar 2025. The FII holding has increased from the last quarter.
Updated on Jul 12, 2025, 06:36 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Eris Lifesciences | Bullish | 1,728.00 | -0.54 | 23,733.68 | 66.44 | 8.2 | 0.43 | 62.42 |
Alembic Pharmaceuticals | Neutral | 975.00 | -0.21 | 19,165.87 | 34.73 | 3.81 | 1.09 | 0.90 |
Jubilant Pharmova | Neutral | 1,156.90 | -1.16 | 18,427.23 | 35.82 | 3.04 | 0.42 | 38.19 |
Natco Pharma | Moderately Bullish | 961.75 | -3.65 | 17,225.89 | 9.25 | 2.29 | 0.62 | 0.06 |
Caplin Point Laboratories | Moderately Bearish | 2,018.20 | -1.17 | 15,394.47 | 28.50 | 5.33 | 0.27 | 0.10 |
Meeting Date | Purpose |
---|---|
2025-05-16 | Audited Results & Final Dividend |
2025-01-31 | Quarterly Results |
2024-10-25 | Quarterly Results |
2024-07-19 | Quarterly Results |
2024-05-29 | Audited Results & Final Dividend |
Jubilant Pharmova is trading at 1156.90 as on Fri Jul 11 2025 09:59:25. This is -1.16% lower as compared to its previous closing price of 1170.50.
The market capitalization of Jubilant Pharmova is 18427.23 Cr as on Fri Jul 11 2025 09:59:25.
The 52 wk high for Jubilant Pharmova is 1309.00 whereas the 52 wk low is 701.40
Jubilant Pharmova can be analyzed on the following key metrics -
Jubilant Pharmova reported a net profit of 839.40 Cr in 2025.
The Mutual Fund Shareholding was 3.66% at the end of 31 Mar 2025.